202 related articles for article (PubMed ID: 31722306)
1. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Nonaka T
Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
[TBL] [Abstract][Full Text] [Related]
2. Application of yeast to studying amyloid and prion diseases.
Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
[TBL] [Abstract][Full Text] [Related]
3. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
4. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
Goedert M; Falcon B; Clavaguera F; Tolnay M
Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
[TBL] [Abstract][Full Text] [Related]
5. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception.
Moda F; Ciullini A; Dellarole IL; Lombardo A; Campanella N; Bufano G; Cazzaniga FA; Giaccone G
Front Biosci (Landmark Ed); 2023 Oct; 28(10):255. PubMed ID: 37919089
[TBL] [Abstract][Full Text] [Related]
6. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
Jaunmuktane Z; Brandner S
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
[TBL] [Abstract][Full Text] [Related]
7. Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.
Tyson T; Steiner JA; Brundin P
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):275-289. PubMed ID: 26617280
[TBL] [Abstract][Full Text] [Related]
8. [Is Parkinson's disease a prion disease?].
Brandel JP; Corbillé AG; Derkinderen P; Haïk S
Rev Neurol (Paris); 2015 Dec; 171(12):812-24. PubMed ID: 26563663
[TBL] [Abstract][Full Text] [Related]
9. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.
Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456
[TBL] [Abstract][Full Text] [Related]
10. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
Braak H; Del Tredici K
Cold Spring Harb Perspect Biol; 2016 Nov; 8(11):. PubMed ID: 27580631
[TBL] [Abstract][Full Text] [Related]
11. Interaction between pathogenic proteins in neurodegenerative disorders.
Jellinger KA
J Cell Mol Med; 2012 Jun; 16(6):1166-83. PubMed ID: 22176890
[TBL] [Abstract][Full Text] [Related]
12. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
Kanouchi T; Ohkubo T; Yokota T
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):739-45. PubMed ID: 22544947
[TBL] [Abstract][Full Text] [Related]
13. Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates.
Caughey B; Kraus A
Viruses; 2019 Nov; 11(11):. PubMed ID: 31717531
[TBL] [Abstract][Full Text] [Related]
14. PrP meets alpha-synuclein: Molecular mechanisms and implications for disease.
Vieira TCRG; Barros CA; Domingues R; Outeiro TF
J Neurochem; 2023 Oct; ():. PubMed ID: 37855859
[TBL] [Abstract][Full Text] [Related]
15. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.
Rey NL; Wesson DW; Brundin P
Neurobiol Dis; 2018 Jan; 109(Pt B):226-248. PubMed ID: 28011307
[TBL] [Abstract][Full Text] [Related]
16. Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism.
Fernández-Borges N; Eraña H; Elezgarai SR; Harrathi C; Gayosso M; Castilla J
Int J Cell Biol; 2013; 2013():583498. PubMed ID: 24187553
[TBL] [Abstract][Full Text] [Related]
17. The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy.
Shehjar F; Almarghalani DA; Mahajan R; Hasan SA; Shah ZA
Cells; 2024 Jan; 13(2):. PubMed ID: 38247879
[TBL] [Abstract][Full Text] [Related]
18. The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates.
Creekmore BC; Chang YW; Lee EB
J Neuropathol Exp Neurol; 2021 Jun; 80(6):514-529. PubMed ID: 33970243
[TBL] [Abstract][Full Text] [Related]
19. New opportunities for treatment and prevention of neurodegenerative diseases with PTP1B inhibitors.
Kołodziej D; Sobczak Ł; Łączkowski KZ
Future Med Chem; 2023 Aug; 15(16):1443-1447. PubMed ID: 37610866
[No Abstract] [Full Text] [Related]
20. Effect of host and strain factors on α-synuclein prion pathogenesis.
Woerman AL; Bartz JC
Trends Neurosci; 2024 May; ():. PubMed ID: 38806297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
